MILLENNIUM MANAGEMENT LLC - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 44 filers reported holding TALIS BIOMEDICAL CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$43,902
+54777.5%
91,463
-44.1%
0.00%
Q1 2023$80
+63.3%
163,663
+47.4%
0.00%
Q4 2022$49
-99.9%
111,036
-14.2%
0.00%
Q3 2022$88,000
-46.3%
129,372
-35.9%
0.00%
Q2 2022$164,000
+4.5%
201,913
+1320.0%
0.00%
Q2 2021$157,00014,2190.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
WELLS FARGO & COMPANY/MN 174$840.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
STATE STREET CORP 47,436$22,7690.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
DEUTSCHE BANK AG\ 45,294$21,7410.00%
MORGAN STANLEY 61,857$29,6910.00%
BlackRock Inc. 76,307$36,6280.00%
View complete list of TALIS BIOMEDICAL CORP shareholders